Cargando…
Treatment with SGLT2 Inhibitors in Patients with Diabetes Mellitus and Extensive Coronary Artery Disease: Mortality and Cardiovascular Outcomes
INTRODUCTION: Sodium-glucose type 2 cotransporter inhibitors (SGLT2-I) have shown solid benefits in reducing cardiovascular mortality and admissions for heart failure in patients with type 2 diabetes mellitus (T2DM) and cardiovascular disease. However, no specific studies exist in patients with high...
Autores principales: | Chipayo-Gonzales, David, Shabbir, Asad, Vergara-Uzcategui, Carlos, Nombela-Franco, Luis, Jimenez-Quevedo, Pilar, Gonzalo, Nieves, Nuñez-Gil, Ivan, Mejia-Renteria, Hernan, Macaya-Ten, Fernando, Tirado-Conte, Gabriela, Perez-Vizcayno, Maria Jose, Fuentes, Manuel, Escaned, Javier, Fernandez-Ortiz, Antonio, Salinas, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570247/ https://www.ncbi.nlm.nih.gov/pubmed/37665429 http://dx.doi.org/10.1007/s13300-023-01454-w |
Ejemplares similares
-
Pancoronary vasospasm with out-of-hospital cardiac arrest
por: Shabbir, Asad, et al.
Publicado: (2023) -
Safety of coronary revascularization deferral based on fractional flow reserve and instantaneous wave-free ratio in patients with chronic kidney disease
por: Travieso, Alejandro, et al.
Publicado: (2022) -
Transcatheter Treatment of Mitral Regurgitation
por: McInerney, Angela, et al.
Publicado: (2022) -
Propensity-matched analysis of long-term clinical results after ostial circumflex revascularisation
por: Espejo-Paeres, Carolina, et al.
Publicado: (2023) -
Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study
por: Vergara-Uzcategui, Carlos E., et al.
Publicado: (2023)